vancomycin has been researched along with mefloquine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aldrich, CC; Cui, H; Ferguson, DM; Guo, K; Larson, P; Li, Y; Liu, X; Ma, C; Sheng, L; Wang, S; Wang, X; Zeng, Y; Zhang, G; Zhang, J; Zou, X | 1 |
Ellis, WY; Kunin, CM | 1 |
1 review(s) available for vancomycin and mefloquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for vancomycin and mefloquine
Article | Year |
---|---|
A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Binding Sites; Cinchona Alkaloids; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mitochondrial Proton-Translocating ATPases; Streptococcus pneumoniae; Structure-Activity Relationship | 2019 |
Antimicrobial activities of mefloquine and a series of related compounds.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Drug Synergism; Fungi; Gentamicins; Mefloquine; Microbial Sensitivity Tests; Nucleic Acids; Staphylococcus; Streptococcus pneumoniae; Topoisomerase II Inhibitors; Vancomycin | 2000 |